Digital Diabetes Management Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Digital Diabetes Management Market Report is Segmented by Type (wearable Devices and Handheld Devices), Product (smart Glucose Meters, Continuous Glucose Monitoring Systems, Smart Insulin Pens, Smart Insulin Pumps, Apps), and Geography (North America, Europe, Asia-Pacific, The Middle East and Africa, and Latin America). The Report Offers the Values (in USD) and Volume (in Units) for the Above Segments.

Digital Diabetes Management Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Digital Diabetes Management Market Size

Digital Diabetes Management Market Summary
Study Period 2019 - 2030
Market Size (2025) USD 19.00 Billion
Market Size (2030) USD 32.02 Billion
CAGR (2025 - 2030) 11.00 %
Fastest Growing Market North America
Largest Market North America
Market Concentration Medium

Major Players

Digital Diabetes Management Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Digital Diabetes Management Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Digital Diabetes Management Market Analysis

The Digital Diabetes Management Market size is estimated at USD 19.00 billion in 2025, and is expected to reach USD 32.02 billion by 2030, at a CAGR of greater than 11% during the forecast period (2025-2030).

Patients with diabetes were at higher risk for hospitalizations and complications due to hyper- or hypoglycemia, metabolic comorbidities, and more severe illness from SARS-CoV-2 infection. The maintenance of euglycemia was important to decrease both morbidity and mortality in the hospital setting. According to experts, inpatient use of diabetes technology in patients with proper institutional protocols was safe and improved inpatient glycemic outcomes and reduced hypoglycemia. Such factors gave a boost to the market studied during the pandemic.

Diabetes care, including diet, exercise, and determination of insulin dose and timing, is largely dependent on patient self-management. Digital healthcare plays an important role in the management of diabetes by providing tools and resources to help people with diabetes monitor their blood glucose levels, track their medications and activities, make informed decisions about their diet and exercise, and receive personalized guidance and support. Multiple digital tools and apps have been developed to assist patients and healthcare providers, including electronic medical records, insulin pumps, sensors, glucometers, and other wearables.

Furthermore, in recent decades, many smartphone applications have been developed to facilitate lifestyle management to encourage patients to maintain proper lifestyles through technology-based behavioral therapy. For instance, a single platform automatically integrates various data and contains an artificial intelligence-based food recognition program that replaces the complex manual input of dietary information with a photograph of each meal and becomes an appropriate digital health care option for people with diabetes, such as a mobile health care platform, Auto-Chek Care, can be linked to a glucometer, a sphygmomanometer, a scale with bioelectrical impedance analysis and a watch-type pedometer through Bluetooth, allowing all of the data to be automatically collected on the platform for integrated analysis in a single smartphone application.

In November 2023, BeatO, India's digital health platform focusing on diabetes control and treatment, announced that it would be launching physical touchpoints by collaborating with leading doctors in several micro-markets. With the launch of five such clinics across Delhi/NCR, it will be covering cities across Uttar Pradesh, Madhya Pradesh, Rajasthan, Gujarat, and Odisha over the next 6 months. The digital diabetes clinic aims to incorporate all digital patient data and provide individual virtual or face-to-face visits. Digital diabetes care is evolving as a safe, effective, and cost-saving technology providing modest HbA1c reduction with improved patient satisfaction, thereby achieving improved glycemic control with less frequent and severe hypoglycemic episodes, enhancing the market prospects in the years to come.

Digital Diabetes Management Industry Overview

The digital diabetes management market is semi-consolidated, with a few significant and generic players such as Medtronic, Tandem, and Ypsomed. The major players are working on innovations which is evident from the companies spending on research and developments to strengthen their market presence. Furthermore, key market players are focusing on adopting advanced technologies and introducing new products through collaborations, acquisitions, and government initiatives to offer diabetes patients better services.

Digital Diabetes Management Market Leaders

  1. Abbott

  2. F. Hoffmann-La Roche Ltd.

  3. Insulet Corporation

  4. Dexcom

  5. Medtronic

  6. *Disclaimer: Major Players sorted in no particular order
Digital Diabetes Management Concentration
Need More Details on Market Players and Competiters?
Download PDF

Digital Diabetes Management Market News

  • March 2023: Becton Dickinson launched the BD Diabetes Care App for People living with diabetes, Caregivers, Diabetes Educators, and Physicians. The BD Diabetes Care App’s tools and curriculum-based content are designed to provide trusted information on various topics around diabetes management.
  • February 2023: The University of Pretoria’s (UP) Diabetes Research Centre, in conjunction with health tech company Aviro Health, launched the Aviro Pocket Clinic app for diabetes, which allows for patient registration, guided clinic and home visits for insulin initiation for people with type-2 diabetes as well as lifestyle counseling, among other features.

Digital Diabetes Management Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Drivers
  • 4.3 Restraints
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 Type
    • 5.1.1 Wearable Devices
    • 5.1.2 Handheld Devices
  • 5.2 Product
    • 5.2.1 Smart Glucose meters
    • 5.2.2 Continuous Glucose Monitoring Systems
    • 5.2.3 Smart Insulin Pens
    • 5.2.4 Smart Insulin Pump
    • 5.2.5 Apps
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Rest of North America
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 Spain
    • 5.3.2.3 Italy
    • 5.3.2.4 France
    • 5.3.2.5 United Kingdom
    • 5.3.2.6 Russia
    • 5.3.2.7 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 Japan
    • 5.3.3.2 China
    • 5.3.3.3 Australia
    • 5.3.3.4 India
    • 5.3.3.5 South Korea
    • 5.3.3.6 Malaysia
    • 5.3.3.7 Indonesia
    • 5.3.3.8 Thailand
    • 5.3.3.9 Philippines
    • 5.3.3.10 Vietnam
    • 5.3.3.11 Rest of Asia-Pacific
    • 5.3.4 Latin America
    • 5.3.4.1 Brazil
    • 5.3.4.2 Mexico
    • 5.3.4.3 Rest of Latin America
    • 5.3.5 Middle East and Africa
    • 5.3.5.1 South Africa
    • 5.3.5.2 Saudi Arabia
    • 5.3.5.3 Oman
    • 5.3.5.4 Egypt
    • 5.3.5.5 Iran
    • 5.3.5.6 Rest of Middle East and Africa

6. MARKET INDICATORS

  • 6.1 Type-1 Diabetes population
  • 6.2 Type-2 Diabetes population

7. COMPETITIVE LANDSCAPE

  • 7.1 COMPANY PROFILES
    • 7.1.1 Abbott
    • 7.1.2 F. Hoffmann-La Roche Ltd.
    • 7.1.3 Ascensia Diabetes Care
    • 7.1.4 Becton Dickinson
    • 7.1.5 Medtronic
    • 7.1.6 Bayer AG
    • 7.1.7 LifeScan, Inc.
    • 7.1.8 Dexcom, Inc.
    • 7.1.9 Sanofi
    • 7.1.10 Insulet Corporation
    • 7.1.11 B. Braun Melsungen AG
  • *List Not Exhaustive
  • 7.2 COMPANY SHARE ANALYSIS

8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Digital Diabetes Management Industry Segmentation

Digital health management includes devices, services, and platforms that play an important role in the care of individuals with diabetes and simplify self-management. 

The digital diabetes management market is segmented by type (wearable devices and handheld devices), product (smart glucose meters, continuous glucose monitoring systems, smart insulin pens, smart insulin pumps, apps), and geography (North America, Europe, Asia-Pacific, the Middle East and Africa, and Latin America).

The report offers the values (in USD) and volume (in units) for the above segments.

Type Wearable Devices
Handheld Devices
Product Smart Glucose meters
Continuous Glucose Monitoring Systems
Smart Insulin Pens
Smart Insulin Pump
Apps
Geography North America United States
Canada
Rest of North America
Europe Germany
Spain
Italy
France
United Kingdom
Russia
Rest of Europe
Asia-Pacific Japan
China
Australia
India
South Korea
Malaysia
Indonesia
Thailand
Philippines
Vietnam
Rest of Asia-Pacific
Latin America Brazil
Mexico
Rest of Latin America
Middle East and Africa South Africa
Saudi Arabia
Oman
Egypt
Iran
Rest of Middle East and Africa
Need A Different Region or Segment?
Customize Now

Digital Diabetes Management Market Research FAQs

How big is the Digital Diabetes Management Market?

The Digital Diabetes Management Market size is expected to reach USD 19.00 billion in 2025 and grow at a CAGR of greater than 11% to reach USD 32.02 billion by 2030.

What is the current Digital Diabetes Management Market size?

In 2025, the Digital Diabetes Management Market size is expected to reach USD 19.00 billion.

Who are the key players in Digital Diabetes Management Market?

Abbott, F. Hoffmann-La Roche Ltd., Insulet Corporation, Dexcom and Medtronic are the major companies operating in the Digital Diabetes Management Market.

Which is the fastest growing region in Digital Diabetes Management Market?

North America is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Digital Diabetes Management Market?

In 2025, the North America accounts for the largest market share in Digital Diabetes Management Market.

What years does this Digital Diabetes Management Market cover, and what was the market size in 2024?

In 2024, the Digital Diabetes Management Market size was estimated at USD 16.91 billion. The report covers the Digital Diabetes Management Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Digital Diabetes Management Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Digital Diabetes Management Industry Report

Statistics for the 2025 Digital Diabetes Management market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Digital Diabetes Management analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.